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Abstract
Few prospective studies have examined the effects of different types of dairy food on the risks of type 2 diabetes, CHD and mortality.
We examined whether intakes of total dairy, high-fat dairy, low-fat dairy, milk and fermented dairy products were related to these
outcomes in the Whitehall II prospective cohort study. At baseline, dairy consumption was assessed by FFQ among 4526 subjects
(72 % men) with a mean age 56 (SD 6) years. Death certificates and medical records were used to ascertain CHD mortality and non-
fatal myocardial infarction. Incident diabetes was detected by the oral glucose tolerance test or self-report. Incidence data were analysed
using Cox proportional hazards models, adjusted for lifestyle and dietary factors. During approximately 10 years of follow-up, 273 diabetes,
323 CHD and 237 all-cause mortality cases occurred. In multivariable models, intakes of total dairy and types of dairy products were not
significantly associated with incident diabetes or CHD (all P values for trend .0·1). Fermented dairy products was inversely associated
with overall mortality (hazard ratios approximately 0·7 in the middle and highest tertiles; P for trend ,0·01) but not with incident CHD
or diabetes (P.0·3). In conclusion, intakes of total dairy and types of dairy products showed no consistent relationship with incident
diabetes, CHD or all-cause mortality.
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Diabetes and CHD are both leading causes of hospitalisations,
death and loss of disability-adjusted life years(1,2). A consider-
able proportion of diabetes and CHD incidence can be
prevented or delayed by healthy diet and exercise(3–6).
American and European dietary guidelines for CHD preven-
tion recommend intake of low-fat dairy products(7,8). Prospec-
tive cohort studies investigating the association between milk
consumption and CHD have found conflicting results(9,10). In a
meta-analysis of nine prospective cohort studies, an inverse
association between the highest relative to the lowest dairy
product consumption and CHD was observed, with a relative
risk of 0·92 (95 % CI 0·80, 0·99), but milk was not analysed
separately(9). A recent dose–response meta-analysis pooling
six prospective cohort studies did not show an association
between milk consumption and CHD and all-cause mortality
(relative risk 1·00 (95 % CI 0·96, 1·04) per 200 ml milk)(10).
In this meta-analysis, data on dairy products other than milk
in relation to CHD and all-cause mortality were not pooled
because the number of studies was limited. For incident
diabetes, several meta-analyses (summarising four to seven
prospective cohort studies) reported statistically significant
inverse associations with dairy consumption, especially low-
fat dairy products(9,11,12).
The largest studies in all these meta-analyses(9–12) were
from the USA(13–17) with limited evidence coming from
European studies. Early studies from the UK, the Caerphilly
cohort study (baseline 1979–83)(18,19), and the Oxford
Vegetarian Study (1973)(20) only examined milk and other
types of dairy food were not investigated in relation to dia-
betes, CHD or all-cause mortality. The aim of the present
study was therefore to examine the relationship between
different types of dairy food and incident type 2 diabetes,
fatal and non-fatal CHD, and all-cause mortality using recent
data from the Whitehall II study.
Methods
Study population
The Whitehall II cohort consists of London-based office
staff working in twenty Civil Service departments during
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recruitment in 1985–8. The initial cohort consisted of 10 308
civil servants (6895 men and 3413 women, aged 35–55
years), with a participation rate of 73 %(21). During the
follow-up, FFQ were completed at phase 3 (1991–3), phase
5 (1997–9), phase 7 (2003–4) and phase 9 (2007–9). As the
FFQ-item format for milk intake was shown to be answered
inconsistently at phase 3, the phase 5 FFQ (1997–9) was
selected, completed by 5088 participants, as baseline for the
present study. The study was conducted according to the
guidelines laid down in the Declaration of Helsinki and all
procedures involving human subjects were approved by the
University College London Research Ethics Committee. Written
informed consent was obtained from all subjects during each
phase of the Whitehall II study.
Assessment of dairy intake
The FFQ comprised of 114 items. Breakfast cereals were
assessed in a separate and open question, each participant
being able to report up to two types of cereals. Milk consump-
tion over the previous 12 months was assessed with two sep-
arate questions: first, on the type of milk most often used (full
cream, semi-skimmed, skimmed, Channel Islands, dried, soya,
other or none); second, on the usual daily amount (none,
quarter of a pint, half a pint, three quarters of pint, one pint
or more than one pint).
Consumption of other dairy products (single cream, double
or clotted cream, yogurt, cheese, cottage or low-fat soft
cheese, milk puddings, hot chocolate or Horlicks/Ovaltine)
was reported in predefined frequency categories that ranged
from never/less than once per month to six or more portions
per d. The FFQ was previously validated at phase 3 against a
7 d diary and blood biomarkers, although not for dairy pro-
ducts(22). For Ca, energy-adjusted Spearman’s correlations
were 0·44 and 0·48, for women and men, respectively.
In total, eight exposure variables were created for dairy con-
sumption: total dairy (all dairy products, except butter and ice
cream); high-fat dairy (full-fat cheese, yogurt, milk puddings,
whole and Channel Islands milk); low-fat dairy (cottage
cheese, semi-skimmed, skimmed milk and milk-based hot
drinks); total milk (including whole and low-fat milk); low-
fat milk (semi-skimmed and skimmed); fermented dairy
(yogurt and total cheese); yogurt; total cheese (full-fat
cheese and cottage cheese). Whole milk was consumed in
too limited amounts to examine this separately. We were
unable to distinguish types of yogurt intake as no information
was available on sugar or fat content.
Other measurements
A self-completed questionnaire was used for several diagnoses
(e.g. ever told by a doctor that they had angina, heart attack,
hypertension or diabetes), exercise, diet, alcohol, smoking
status and the last known civil service employment grade
(six categories varying from highest employment grades
defined as unified employment grades 1–6 according to
salary scales, followed in descending order by senior, higher
and executive officer, and clerical/support staff as the lowest
employment grade). Participants subsequently attended a
clinical examination to have a blood sample collected, blood
pressure measured, and height and weight recorded. Blood
pressure was measured twice in the sitting position after a
5 min rest using the Hawksley Random Zero Sphygmoman-
ometer (Hawksley and Sons). Weight was measured using
Soehnle electronic scales. BMI was calculated as weight
divided by the square of height. Total cholesterol and TAG
were determined from fasting serum samples with an Olym-
pus Analyser (AU5200), whereas HDL-cholesterol was deter-
mined with the AU800 Olympus Analyser.
Outcomes
Outcomes included incident diabetes and CHD collected up to
December 2009 and all-cause mortality cases were collected
up to January 2010. In total, 323 cases of fatal and non-fatal
CHD, 237 all-cause deaths, and 273 cases of incident diabetes
occurred during the follow-up period. Participants were
flagged by the National Health Service Central Registry, who
notified us of the date and cause of all deaths up to January
2010. Deaths were classified as coronary if ‘International
Classification of Diseases (ICD)’, 9th edition codes 410–414
or ICD 10th edition codes I20–I25 were present on the
death certificate. ICD-10 codes were I00–I99 for CVD mor-
tality and C00–C97 for cancer mortality. Follow-up for mor-
tality was essentially complete (99·9 % flagged at the
National Health Service Central Registry).
Cases of non-fatal myocardial infarction were identified
from twelve-lead electrocardiograms. In addition, question-
naire items on chest pain using the Rose questions(23) and
doctor’s diagnosis of angina and myocardial infarction were
used. Details of physician investigations, diagnoses and inter-
ventions were sought from medical records for all potential
cases for final ascertainment. Classification, following the
WHO Monitoring of Trends and Determinants in Cardiovascu-
lar disease methods, was carried out independently by two
trained coders, with adjudication in the event of disagreement.
Self-reported myocardial infarction in the absence of verifica-
tion was not classified as myocardial infarction.
Incident cases of diabetes were identified by self-report of
doctor’s diagnosis, initiation of anti-diabetic medication (oral
hypoglycaemic agents or insulin) and a 2 h 75 g oral glucose
tolerance test at phases 5, 7 and 9, according to the 1999
WHO classification.
Statistical methods
Consumption of total dairy and dairy subgroups was adjusted
for total energy intake (EI) according to the residual
method(24). For each exposure variable, residuals were
obtained by the regression of EI from the selected dairy pro-
ducts v. total EI. Participants were then ranked in sex-specific
tertiles according to their residual values. Tertiles were
included in Cox proportional hazards regression models, the
reference group being the tertile with the lowest intake for
each exposure variable. Follow-up time in years was used as
the time variable. Scaled Schoenfeld residuals were used to
S. S. Soedamah-Muthu et al.2
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Table 1. Baseline characteristics within sex-specific tertiles of energy-adjusted total dairy intake
(Mean values and standard deviations)
Tertile*
1 (n 1506) 2 (n 1501) 3 (n 1519)
Mean SD Mean SD Mean SD
Median total dairy intake (g/d) 246 371 575
Age (years) 55·3 6·02 56·1 6·09 56·1 6·02
Sex (male)
% 75·4 69·8 70·3
n 1136 1048 1068
Caucasian
% 92·9 93·7 95·7
n 1399 1406 1454
Smoking
No smoking 49·3 743 52·4 787 55·2 839
Current smoking
% 8·9 8·7 9·0
n 134 130 136
Ex-smoking
% 41·8 38·9 35·8
n 629 584 544
Alcohol consumption
No alcohol consumption 8·6 130 8·1 121 11·1 168
Moderate alcohol consumption (#3·5 units/d)
% 63·5 75·7 75·6
n 956 1136 1148
High alcohol consumption (.3·5 units/d)
% 27·9 16·3 13·4
n 420 244 203
Employment grade
High employment grade (UG1–6)
% 24·2 22·7 20·5
n 365 340 312
Low employment grade
% 10·8 10·7 12·2
n 163 161 185
Physical activity
Sedentary
% 14·7 13·8 13·6
n 222 207 206
Moderately active
% 32·3 31·2 27·8
n 487 468 422
Vigorously active
% 52·9 55·0 58·7
n 797 826 891
Family history of CHD or hypertension
% 52·7 54·2 50·2
n 794 814 763
BMI (kg/m2) 25·8 3·8 25·9 3·8 25·9 3·9
Systolic BP (mmHg) 123 16·4 124 16·7 122 16·4
Diastolic BP (mmHg) 77·7 10·4 77·5 10·5 77·0 10·6
Serum cholesterol (mmol/l) 6·0 1·1 5·9 1·0 5·9 1·0
Serum HDL-cholesterol (mmol/l) 1·5 0·4 1·5 0·4 1·5 0·4
Serum TAG (mmol/l) 1·4 0·9 1·4 0·8 1·3 0·8
Dietary variables
Energy intake (kJ/d) 9904 3005 8841 2540 9565 2861
Total fat (g/d) 82·5 33·4 73·9 27·8 83·5 33·5
Saturated fat (g/d) 30·3 14·4 29·0 12·7 34·7 14·9
Polyunsaturated fat (g/d) 18·1 9·0 14·7 6·7 14·9 7·7
Ca (mg/d) 935 321 1042 306 1397 404
Na (mg/d) 2866 1109 2574 964 2828 1053
K (mg/d) 4233 1207 3913 1019 4289 1120
Fruits and vegetables (g/d) 753 395 663 311 685 337
Bread (g/d) 103 68·8 85·9 59·6 85·0 59·1
Meat (g/d) 133 93·1 110 59·1 103 57·8
Fish (g/d) 44·1 36·4 37·1 28·9 35·4 25·9
Coffee (dry g/d)† 3·8 3·4 3·6 3·3 3·8 3·4
Tea (g/d)‡ 473 354 515 351 544 373
UG1–6, unified employment grades (code 1, highest salary; code 6, lowest salary); BP, blood pressure.
* Tertiles are sex-specific.
†Expressed as dry weight.
‡Expressed as consumed weight.
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test the proportional hazards assumption which was met for
all models. Outcomes included incident cases only. Both
linear and quadratic trends were examined with Cox pro-
portional hazards regression models.
For each exposure–outcome combination, three models
were run. In the first model, adjustments were made for age
(continuous), ethnicity (white Caucasians as the reference
group, south Asian, black and other ethnicity) and employ-
ment grade (high employment grade as the reference
group). The second model additionally included smoking
status (never smoking as the reference group, current and
past), alcohol intake (no consumption as the reference
group, moderate (#3·5 units/d) and high alcohol intake
(.3·5 units/d)), BMI (continuous), physical activity level
(inactive as the reference group, moderately active and
vigorously active) and family history of CHD or hypertension
(yes/no). In the third model, further adjustments were made
for intake of fruit, vegetables, bread, meat, fish, coffee, tea
and total energy (all continuous). We additionally adjusted
for BMI changes between phase 5 (1997–9) and phase
7 (2003–4) using the third model. Also, analyses were rerun
to investigate the effect of energy misreporting. BMR was cal-
culated using the 1991 Committee on Medical Aspects of Food
Policy equations(25). The ratio of the EI:BMR (EI:BMR) was
then calculated for each individual. Participants with EI:BMR
,1·14 were classified as ‘energy under-reporters’ based on
the cut-off limits developed by Goldberg et al.(26,27), whereas
those with EI:BMR .2·24 as over-reporters. Normal energy
reporters were participants with 1·14 # EI:BMR # 2·24.
To take the disparity in consumption levels across tertiles
into account when comparing hazard ratios (HR) between
dairy products, the HR per standard deviation unit were
calculated.
Of the 5088 participants who completed the FFQ, ninety-
nine participants were excluded due to missing dairy intake
information and 463 participants were excluded with missing
values for confounders, leaving a sample of 4526 participants
for complete case analysis. For the outcome response rates,
there were 133 missing values for incident diabetes, eleven
missing values for incident CHD and four missing values for
all-cause mortality (in total, 4522 participants). For the ana-
lyses with incident diabetes, prevalent diabetes (n 207) cases
were excluded, leaving 4186 participants for the diabetes
analyses. For the analyses with incident CHD, all prevalent
CHD cases (n 260) were excluded, leaving 4255 participants
for the CHD analyses.
Results
The characteristics of 4526 participants are shown by tertiles of
energy-adjusted total dairy consumption in Table 1. The mean
age at baseline was 56 (SD 6·1) years, 72 % were male and the
mean BMI was 25·9 (SD 3·8) kg/m2. The median total dairy
consumption ranged from 246 g/d in the first tertile to 575 g/d
in the third tertile. Overall, median intakes were 378 g/d for
total dairy, 73 g/d for high-fat dairy, 294 g/d for low-fat
dairy, 294 ml/d for total milk, 41 g/d for fermented dairy
products, 21 g/d for yogurt and 17 g/d for cheese. Higher
consumption of dairy products was significantly inversely
associated with physical activity (P¼0·03), consumption of
alcohol, bread, meat, fish and PUFA (all P,0·01), and posi-
tively with ethnicity, tea, Ca and saturated fat (all P,0·01).
Type 2 diabetes
A total of 4186 participants without prevalent diabetes were
followed for 9·8 (SD 1·9) years. There were 273 incident
type 2 diabetes cases available for complete case analysis.
Uni- and multivariable Cox proportional hazards models for
various dairy products and incident type 2 diabetes are
presented in Table 2. In the final adjusted models, total
dairy products were marginally positively, but not significantly,
associated with incident type 2 diabetes with HR of 1·3 in the
highest tertile. Intakes of high- and low-fat dairy, total milk,
low-fat milk, fermented dairy products, yogurt and cheese
were not associated with incident diabetes. Additional adjust-
ments for changes in BMI during the follow-up did not alter
any of the results for diabetes (data not shown).
CHD
A total of 4255 participants were followed for 10·8 (SD 2·6)
years. There were 323 incident CHD cases available for com-
plete case analysis. Intakes of total dairy, high-fat and low-fat
dairy, total milk, low-fat milk, fermented dairy products,
yogurt and cheese were not statistically significantly associated
with incident CHD (Table 3). The majority of these dairy
products (total dairy, low-fat dairy products, total milk, low-
fat milk and cheese) were marginally inversely associated
with incident CHD with HR between 0·8 and 0·9 in the final
adjusted models. Additional adjustments for changes in BMI
during the follow-up did not alter any of the results for CHD
(data not shown).
All-cause mortality
A total of 4522 participants were followed for 11·7 (SD 1·5) years.
There were 237 deaths available for complete case analysis.
Total dairy consumption was non-linearly inversely associated
with all-cause mortality (P for quadratic trend¼0·008; Table 4),
with HR of 0·72 (95 % CI 0·52, 0·99) in the highest tertile
of model 3. No association with mortality was found for con-
sumption of high- or low-fat dairy, with HR of 0·83 and 0·84
(P for trend.0·25). There were no statistically significant asso-
ciations of total milk (HR ¼ 0·89), low-fat milk (HR ¼ 0·82)
and total cheese (HR ¼ 1·00) with all-cause mortality.
Fermented dairy consumption was inversely associated with
all-cause mortality with HR of 0·65 (95 % CI 0·47, 0·90) in the
highest tertile (model 3, P for trend ,0·01). This association
remained after adjustment for intake of other dairy products
(HR 0·62, 95 % CI 0·44, 0·89 in the highest tertile of model 3;
P for trend¼0·006). The association between fermented
dairy consumption and all-cause mortality was also examined
for yogurt and cheese separately, expressed as HR per
SD unit (SD for cheese and yogurt were, respectively, 22·3
and 61·6 g/d). Cheese was not associated with all-cause
S. S. Soedamah-Muthu et al.4
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mortality (HR 1·01 per SD, 95 % CI 0·88, 1·16). For yogurt,
a borderline inverse association was found (HR 0·88 per SD,
95 % CI 0·74, 1·02).
Additional adjustments for changes in BMI during the
follow-up did not alter any of the results for all-cause mortality
(data not shown).
Post hoc analyses
Total dairy intake was no longer associated with all-cause
mortality after excluding fermented dairy consumption from
this group (HR 1·01, 95 % CI 0·72, 1·42 in the highest tertile).
Fermented dairy intake was inversely associated with all-
cause mortality but not with diabetes and CHD. In a post
hoc analysis, we further examined the associations with CVD
(n 53) and cancer mortality (n 126). For fatal CVD, the HR
was 0·69 (95 % CI 0·35, 1·36 model 3, P for trend¼0·28) in
the highest v. lowest tertile. For cancer mortality, the HR
was 0·59 (95 % CI 0·39, 0·91) in the highest v. lowest tertile
(model 3, P for trend¼0·01).
The effect of energy misreporting was assessed. We had 992
under-reporters, 2889 acceptable reporters and 173 over-
reporters. Exclusion of under- and/or over-reporters from
the analysis did not alter the results of Tables 2–4.
Table 2. Association between dairy intake and the 10-year risk of diabetes in 4186 participants of the Whitehall II study
(Hazard ratios and 95% confidence intervals)
Tertiles of sex- and energy-adjusted intake
1 2 3
Hazard ratio Hazard ratio 95% CI Hazard ratio 95% CI P for trend
Total dairy
Median intake (g/d) 246 371 575
No. of subjects/cases 1379/85 1403/95 1404/93
Model 1* Ref 1·10 0·82, 1·48 1·13 0·84, 1·51 0·44
Model 2† Ref 1·16 0·86, 1·56 1·15 0·85, 1·56 0·36
Model 3‡ Ref 1·24 0·92, 1·69 1·30 0·95, 1·77 0·11
High-fat dairy
Median intake (g/d) 27 67 182
No. of subjects/cases 1378/92 1389/84 1419/97
Model 1* Ref 0·89 0·66, 1·20 1·12 0·84, 1·50 0·43
Model 2† Ref 0·93 0·69, 1·25 1·15 0·86, 1·54 0·34
Model 3‡ Ref 0·96 0·71, 1·32 1·23 0·91, 1·67 0·17
Low-fat dairy
Median intake (g/d) 28 294 458
No. of subjects/cases 1403/98 1385/81 1398/94
Model 1* Ref 0·83 0·62, 1·12 0·91 0·69, 1·22 0·54
Model 2† Ref 0·83 0·62, 1·12 0·93 0·70, 1·25 0·64
Model 3‡ Ref 0·85 0·63, 1·14 0·98 0·73, 1·31 0·88
Total milk
Median intake (ml/d) 147 294 441
No. of subjects/cases 1397/97 1379/92 1410/84
Model 1* Ref 0·95 0·71, 1·26 0·88 0·65, 1·18 0·39
Model 2† Ref 1·01 0·76, 1·35 0·90 0·66, 1·21 0·48
Model 3‡ Ref 1·04 0·78, 1·39 0·97 0·71, 1·32 0·86
Fermented dairy
Median intake (g/d) 17 40 105
No. of subjects/cases 1377/91 1385/87 1424/95
Model 1* Ref 0·99 0·73, 1·32 1·11 0·83, 1·48 0·50
Model 2† Ref 1·00 0·74, 1·34 1·12 0·84, 1·50 0·45
Model 3‡ Ref 1·04 0·76, 1·40 1·17 0·87, 1·58 0·31
Yogurt
Median intake (g/d) 0 21 117
No. of subjects/cases 1395/95 1361/85 1430/93
Model 1* Ref 0·86 0·64, 1·15 0·91 0·68, 1·21 0·52
Model 2† Ref 0·92 0·68, 1·23 1·02 0·76, 1·37 0·91
Model 3‡ Ref 0·93 0·69, 1·27 1·04 0·77, 1·42 0·77
Cheese
Median intake (g/d) 6 17 31
No. of subjects/cases 1391/86 1393/97 1402/90
Model 1* Ref 1·17 0·87, 1·57 1·24 0·92, 1·67 0·16
Model 2† Ref 1·11 0·83, 1·49 1·14 0·85, 1·54 0·38
Model 3‡ Ref 1·15 0·85, 1·56 1·20 0·88, 1·64 0·25
Ref, reference.
*Model 1: adjusted for age, ethnicity and employment grade.
†Model 2: model 1þsmoking, alcohol intake, BMI, physical activity and family history of CHD/hypertension.
‡Model 3: model 2 þ fruit and vegetables, bread, meat, fish, coffee, tea and total energy intake.
Dairy products and diabetes, CHD and mortality 5
B
ri
ti
sh
Jo
u
rn
al
o
f
N
u
tr
it
io
n
Discussion
The present prospective cohort study in 4000 adult men and
women showed no consistent associations of total dairy and
types of dairy food intake with incident type 2 diabetes,
CHD or all-cause mortality.
A total of 10 308 subjects were enrolled in the Whitehall II
study (phase I). A FFQ that contained information on different
types of dairy products was introduced 10 years later (phase 5)
and completed by 5088 subjects (49 %). These subjects
smoked less and had a lower BMI, higher employment
grade and lower blood pressure compared with those not
included in the present analysis. Whitehall II study participants
are office-based civil servants and therefore not fully represen-
tative of the total UK population. However, we consider it
unlikely that the relationship between dairy product intakes
and the outcomes in the present study would differ from
that in the general population.
We used a validated FFQ(24) that ranked individuals suffi-
ciently for Ca when compared with 7 d food diaries and bio-
markers with energy-adjusted Spearman’s correlations of
0·44–0·48(22). A disadvantage of the FFQ is that it is
memory-based, which could lead to under- or over-reporting
of food intake(28). We did not update dietary data during the
follow-up, which is a limitation of the present analysis.
Table 3. Association between dairy intake and the 10-year risk of fatal and non-fatal CHD in 4255 participants of the
Whitehall II study
(Hazard ratios and 95% confidence intervals)
Tertiles of sex- and energy-adjusted intake
1 2 3
Hazard ratio Hazard ratio 95% CI Hazard ratio 95% CI P for trend
Total dairy intake
Median intake (g/d) 246 371 575
No. of subjects/cases 1413/112 1403/112 1439/99
Model 1* Ref 0·95 0·73, 1·23 0·83 0·64, 1·09 0·19
Model 2† Ref 0·98 0·75, 1·27 0·87 0·66, 1·15 0·33
Model 3‡ Ref 1·03 0·78, 1·35 0·91 0·68, 1·22 0·53
High-fat dairy
Median intake (g/d) 27 67 182
No. of subjects/cases 1394/111 1411/107 1450/105
Model 1* Ref 0·95 0·73, 1·25 0·93 0·71, 1·22 0·60
Model 2† Ref 0·99 0·76, 1·29 0·96 0·73, 1·26 0·77
Model 3‡ Ref 1·06 0·80, 1·39 1·02 0·77, 1·34 0·91
Low-fat dairy
Median intake (g/d) 28 294 458
No. of subjects/cases 1445/123 1399/92 1411/108
Model 1* Ref 0·77 0·59, 1·02 0·86 0·66, 1·11 0·23
Model 2† Ref 0·78 0·59, 1·02 0·87 0·67, 1·13 0·28
Model 3‡ Ref 0·79 0·60, 1·04 0·87 0·67, 1·14 0·31
Total milk
Median intake (ml/d) 147 294 441
No. of subjects/cases 1416/116 1400/96 1439/111
Model 1* Ref 0·81 0·62, 1·06 0·88 0·67, 1·14 0·33
Model 2† Ref 0·83 0·63, 1·09 0·92 0·70, 1·19 0·52
Model 3‡ Ref 0·85 0·64, 1·12 0·93 0·71, 1·23 0·62
Fermented dairy
Median intake (g/d) 17 40 105
No. of subjects/cases 1390/110 1421/113 1444/100
Model 1* Ref 1·02 0·78, 1·33 0·92 0·70, 1·21 0·54
Model 2† Ref 1·04 0·80, 1·35 0·92 0·70, 1·21 0·57
Model 3‡ Ref 1·10 0·84, 1·44 0·97 0·73, 1·28 0·83
Yogurt
Median intake (g/d) 0 21 117
No. of subjects/cases 1420/105 1396/106 1439/112
Model 1* Ref 1·06 0·81, 1·39 1·10 0·84, 1·45 0·47
Model 2† Ref 1·12 0·85, 1·47 1·18 0·90, 1·55 0·24
Model 3‡ Ref 1·18 0·90, 1·56 1·23 0·93, 1·63 0·15
Cheese
Median intake (g/d) 6 17 31
No. of subjects/cases 1401/118 1424/115 1430/90
Model 1* Ref 0·98 0·76, 1·27 0·78 0·59, 1·03 0·09
Model 2† Ref 0·97 0·75, 1·26 0·77 0·58, 1·02 0·07
Model 3‡ Ref 1·02 0·78, 1·33 0·82 0·61, 1·09 0·17
Ref, reference.
*Model 1: adjusted for age, ethnicity and employment grade.
†Model 2: model 1þsmoking, alcohol intake, BMI, physical activity and family history of CHD/hypertension.
‡Model 3: model 2 þ fruit and vegetables, bread, meat, fish, coffee, tea and total energy intake.
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Although correction for energy misreporting and changes in
BMI during the follow-up did not alter the present results,
we cannot exclude the possibility that misclassification of sub-
jects for dairy intake biased the results from the present study
towards the null. Several objective biomarkers for dairy fat
intake have been proposed, which showed conflicting
relationships with CHD(29,30). We had no biomarker data avail-
able in the Whitehall II study to perform such analyses.
There were no statistically significant associations between
dairy food intake and incident type 2 diabetes. Previous
meta-analyses(9,11,12) and prospective cohort studies(31–36)
reported inverse associations between low-fat dairy intake
and incident type 2 diabetes. In the most recent meta-analyses,
inverse associations of total dairy intake and diabetes were
found in women, but not in men(12). In the UK Caerphilly
cohort study, there was no significant association between
milk consumption and incident diabetes in men who had
kept 7 d weighed intake records(19). Our cohort consisted of
72 % male participants, and we did not find an association
with diabetes, which is in line with previous studies showing
no relationship in men(12,19). We have no likely explanation
why women would be more responsive to dairy intake than
men with respect to diabetes.
In the present study, no associations were found between
dairy food intake and incident CHD. This finding was in
accordance with a recent meta-analysis, which also reported
Table 4. Association between dairy intake and the 12-year risk of all-cause mortality in 4522 participants of the Whitehall II study
(Hazard ratios and 95% confidence intervals)
Tertiles of sex- and energy-adjusted dairy intake
1 2 3
Hazard ratio Hazard ratio 95% CI Hazard ratio 95% CI P for trend
Total dairy intake
Median intake (g/d) 246 371 575
No. of subjects/cases 1504/104 1501/60 1517/73
Model 1* Ref 0·53 0·39, 0·73 0·64 0·47, 0·87 ,0·01
Model 2† Ref 0·56 0·41, 0·78 0·69 0·51, 0·93 0·01
Model 3‡ Ref 0·57 0·41, 0·79 0·72 0·52, 0·99 0·04
High fat dairy
Median intake (g/d) 27 67 182
No. of subjects/cases 1506/92 1499/70 1517/75
Model 1* Ref 0·75 0·55, 1·03 0·82 0·60, 1·12 0·20
Model 2† Ref 0·76 0·55, 1·04 0·83 0·61, 1·13 0·22
Model 3‡ Ref 0·74 0·53, 1·02 0·83 0·60, 1·14 0·25
Low fat dairy
Median intake (g/d) 28 294 458
No. of subjects/cases 1512/90 1501/77 1509/70
Model 1* Ref 0·83 0·61, 1·13 0·71 0·52, 0·97 0·03
Model 2† Ref 0·90 0·66, 1·22 0·79 0·57, 1·08 0·14
Model 3‡ Ref 0·90 0·66, 1·23 0·84 0·60, 1·16 0·28
Total milk
Median intake (ml/d) 147 294 441
No. of subjects/cases 1502/86 1501/80 1519/71
Model 1* Ref 0·90 0·66, 1·22 0·77 0·56, 1·05 0·10
Model 2† Ref 0·93 0·68, 1·27 0·80 0·58, 1·11 0·18
Model 3‡ Ref 0·98 0·72, 1·34 0·89 0·64, 1·25 0·51
Fermented dairy
Median intake (g/d) 17 40 105
No. of subjects/cases 1498/100 1496/70 1528/67
Model 1* Ref 0·69 0·51, 0·93 0·66 0·48, 0·90 ,0·01
Model 2† Ref 0·69 0·51, 0·94 0·68 0·50, 0·93 0·01
Model 3‡ Ref 0·66 0·48, 0·91 0·65 0·47, 0·90 ,0·01
Yogurt
Median intake (g/d) 0 21 117
No. of subjects/cases 1497/84 1494/92 1531/61
Model 1* Ref 1·07 0·80, 1·45 0·67 0·48, 0·94 0·02
Model 2† Ref 1·15 0·85, 1·55 0·76 0·55, 1·07 0·14
Model 3‡ Ref 1·13 0·83, 1·53 0·74 0·53, 1·05 0·10
Cheese
Median intake (g/d) 6 17 31
No. of subjects/cases 1510/83 1509/73 1503/81
Model 1* Ref 0·93 0·68, 1·27 1·05 0·77, 1·43 0·76
Model 2† Ref 0·91 0·67, 1·25 1·01 0·74, 1·37 0·96
Model 3‡ Ref 0·90 0·65, 1·25 1·00 0·72, 1·37 0·99
Ref, reference.
*Model 1: adjusted for age, ethnicity and employment grade.
†Model 2: model 1 þ smoking, alcohol intake, BMI, physical activity and family history of CHD/hypertension.
‡Model 3: model 2 þ fruit and vegetables, bread, meat, fish, coffee, tea and total energy intake.
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no associations between milk consumption and incident CHD
on the basis of six prospective cohort studies (HR 1·00, 95 % CI
0·96, 1·04)(10). In another meta-analysis of nine prospective
studies, an inverse association between milk (and dairy
food) and CHD has been reported (HR 0·92, 95 % CI 0·80,
0·99 for the highest relative to lowest intake)(9), but the results
were attenuated when types of milk were taken into account
for one large study contributing to this meta-analysis(14).
We found an inverse association between fermented dairy
intake and all-cause mortality, but not with diabetes and
CHD. This appeared to be due to yogurt rather than cheese
intake, although this finding needs confirmation in further
studies. In a previous Dutch study on 120 852 men and
women followed for 10 years, fermented full-fat milk was
also inversely related to all-cause mortality, with relative risks
of 0·91 (95 % CI 0·86, 0·97) in men and 0·92 (95 % CI 0·85, 1·00)
in women per intake of 100 g/d. The group of fermented dairy
in that study, however, contained other products (full-fat
yogurt, quark, fresh cheese and sour cream) different from
that used in the present study (soft and hard cheese and
yogurt), which makes these studies not fully comparable(37).
There is some evidence that vitamin K2 present in fermented
dairy products plays a role in apoptosis and cell-cycle arrest
influencing carcinogenesis(38,39), which may explain the associ-
ations with cancer(40) in the present post hoc analyses. On the
other hand, fermented dairy consumption could be a marker
of healthy food choices in general and residual confounding
cannot be ruled out completely.
In conclusion, total dairy and types of dairy food consump-
tion were not associated with diabetes, CHD or all-cause
mortality in the present prospective cohort study of London-
based civil servants. We observed an inverse relationship of
fermented dairy products with all-cause mortality, which
needs confirmation in further studies.
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